CARL
NASDAQ HealthcareCarlsmed, Inc. - Common Stock
Health Information Services
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
๐ Market Data
| Price | $9.48 |
|---|---|
| Volume | 102,126 |
| Market Cap | 258.16M |
| RSI (14-Day) | 47.7 |
| 50-Day MA | $10.91 |
| 52-Week High | $17.19 |
| 52-Week Low | $8.50 |
| Forward P/E | -6.38 |
| Price / Book | 2.55 |
๐ฏ Investment Strategy Scores
CARL scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (65/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ Institutional Whale (5/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find CARL in your text
Paste any article, transcript, or post โ the tool will extract CARL and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.